Role of Endothelin-1 in Blood Pressure Regulation in a Rat Model of Visceral Obesity and Hypertension

ABSTRACT—Endothelial dysfunction has been suggested to play an important role in the development of obesity-induced hypertension. Because endothelin release increases in response to endothelial damage, we examined whether endothelin-1 contributes to increased arterial pressure in a model of visceral...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hypertension (Dallas, Tex. 1979) Tex. 1979), 2004-02, Vol.43 (2, Part 2), p.383-387
Hauptverfasser: da Silva, Alexandre A, Kuo, Jay J, Tallam, Lakshmi S, Hall, John E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 387
container_issue 2, Part 2
container_start_page 383
container_title Hypertension (Dallas, Tex. 1979)
container_volume 43
creator da Silva, Alexandre A
Kuo, Jay J
Tallam, Lakshmi S
Hall, John E
description ABSTRACT—Endothelial dysfunction has been suggested to play an important role in the development of obesity-induced hypertension. Because endothelin release increases in response to endothelial damage, we examined whether endothelin-1 contributes to increased arterial pressure in a model of visceral obesity produced by feeding Sprague-Dawley rats a high-fat (HF) diet (40% fat w/w, n=6) for 12 months. Arterial and venous catheters were implanted for measurement of mean arterial pressure (MAP) and heart rate (HR) 24 hours per day and intravenous infusions. After a 5-day control period, rats were infused with the selective endothelin-1 type A receptor (ET-A) blocker ABT-627 (2.5 mg/kg per day, IV) for 9 days, followed by a recovery period. Rats fed a standard chow (normal fat, or NF, groupn=6) for 12 months were also infused with ET-A blocker and were used as controls. Compared with NF rats, HF rats had higher MAP (113±4 versus 98±2 mm Hg), increased visceral fat (18.7±2.0 versus 10.8±1.4 g), and 3.2-fold increase in plasma leptin despite similar total body weight gain. Long-term ET-A blockade markedly reduced MAP in HF (−14±3 mm Hg) and NF (−14±2 mm Hg), but it had no effect on HR, GFR, or PRA. These results indicate that a long-term HF diet may cause visceral obesity and increased MAP, even in the absence of major changes in total body weight. Endothelin-1 appears to play an important role in the maintenance of arterial pressure in rats fed HF and NF diets, but it does not appear to contribute to increased MAP in this model of diet-induced hypertension.
doi_str_mv 10.1161/01.HYP.0000111139.94378.74
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80128446</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80128446</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5106-dc94c2cbd1a6535665000d766d2d39bd597c7ed3388e7b597947a0627c085d6f3</originalsourceid><addsrcrecordid>eNpdkV9v0zAUxS3ExErhKyBrEntLZjv-k_AG00aRhjZVgODJcuwbmuHGxU409dvjrJUqcV-uLP-O7_E9CF1QUlIq6RWh5erXQ0ly0VxVUza8UnWp-Au0oILxggtZvUQLQhteNJT-PEevU3rMOOdcvULnlCuiqOQLBOvgAYcO3wwujBvw_VBQ3A_4kw_B4YcIKU0R8Bp-T96MfRjmS4PXZsRfgwM_a3_0yUI0Ht-3kPpxj83g8Gq_gzjCkLLmDTrrjE_w9tiX6PvtzbfrVXF3__nL9ce7wgpKZOFswy2zraNGikpIKfIXnZLSMVc1rRONsgpcVdU1qDafGq4MkUxZUgsnu2qJLg_v7mL4O0Ea9Xa25r0ZIExJ14SymnOZwYv_wMcwxSF704wIpmqW97pEHw6QjSGlCJ3exX5r4l5TouckNKE6J6FPSejnJLTiWfzuOGFqt-BO0uPqM_D-CJhkje-iGWyfTpwQtSJydsEP3FPwI8T0x09PEPUGjB83z6M5k3XBcieMUFLMZmT1D06Hn08</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>205278211</pqid></control><display><type>article</type><title>Role of Endothelin-1 in Blood Pressure Regulation in a Rat Model of Visceral Obesity and Hypertension</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Journals@Ovid Complete</source><creator>da Silva, Alexandre A ; Kuo, Jay J ; Tallam, Lakshmi S ; Hall, John E</creator><creatorcontrib>da Silva, Alexandre A ; Kuo, Jay J ; Tallam, Lakshmi S ; Hall, John E</creatorcontrib><description>ABSTRACT—Endothelial dysfunction has been suggested to play an important role in the development of obesity-induced hypertension. Because endothelin release increases in response to endothelial damage, we examined whether endothelin-1 contributes to increased arterial pressure in a model of visceral obesity produced by feeding Sprague-Dawley rats a high-fat (HF) diet (40% fat w/w, n=6) for 12 months. Arterial and venous catheters were implanted for measurement of mean arterial pressure (MAP) and heart rate (HR) 24 hours per day and intravenous infusions. After a 5-day control period, rats were infused with the selective endothelin-1 type A receptor (ET-A) blocker ABT-627 (2.5 mg/kg per day, IV) for 9 days, followed by a recovery period. Rats fed a standard chow (normal fat, or NF, groupn=6) for 12 months were also infused with ET-A blocker and were used as controls. Compared with NF rats, HF rats had higher MAP (113±4 versus 98±2 mm Hg), increased visceral fat (18.7±2.0 versus 10.8±1.4 g), and 3.2-fold increase in plasma leptin despite similar total body weight gain. Long-term ET-A blockade markedly reduced MAP in HF (−14±3 mm Hg) and NF (−14±2 mm Hg), but it had no effect on HR, GFR, or PRA. These results indicate that a long-term HF diet may cause visceral obesity and increased MAP, even in the absence of major changes in total body weight. Endothelin-1 appears to play an important role in the maintenance of arterial pressure in rats fed HF and NF diets, but it does not appear to contribute to increased MAP in this model of diet-induced hypertension.</description><identifier>ISSN: 0194-911X</identifier><identifier>EISSN: 1524-4563</identifier><identifier>DOI: 10.1161/01.HYP.0000111139.94378.74</identifier><identifier>PMID: 14707164</identifier><identifier>CODEN: HPRTDN</identifier><language>eng</language><publisher>Philadelphia, PA: American Heart Association, Inc</publisher><subject>Adipose Tissue - pathology ; Animals ; Arterial hypertension. Arterial hypotension ; Biological and medical sciences ; Blood and lymphatic vessels ; Blood Pressure - drug effects ; Body Weight ; Cardiology. Vascular system ; Clinical manifestations. Epidemiology. Investigative techniques. Etiology ; Eating ; Endothelin A Receptor Antagonists ; Endothelin-1 - physiology ; Experimental diseases ; Fats - administration &amp; dosage ; Heart Rate - drug effects ; Hormones - blood ; Hypertension - etiology ; Hypertension - physiopathology ; Kidney - drug effects ; Kidney - physiopathology ; Male ; Medical sciences ; Obesity - complications ; Obesity - etiology ; Obesity - pathology ; Pyrrolidines - pharmacology ; Rats ; Rats, Sprague-Dawley ; Viscera</subject><ispartof>Hypertension (Dallas, Tex. 1979), 2004-02, Vol.43 (2, Part 2), p.383-387</ispartof><rights>2004 American Heart Association, Inc.</rights><rights>2004 INIST-CNRS</rights><rights>Copyright American Heart Association, Inc. Feb 2004</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5106-dc94c2cbd1a6535665000d766d2d39bd597c7ed3388e7b597947a0627c085d6f3</citedby><cites>FETCH-LOGICAL-c5106-dc94c2cbd1a6535665000d766d2d39bd597c7ed3388e7b597947a0627c085d6f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3674,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15587061$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14707164$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>da Silva, Alexandre A</creatorcontrib><creatorcontrib>Kuo, Jay J</creatorcontrib><creatorcontrib>Tallam, Lakshmi S</creatorcontrib><creatorcontrib>Hall, John E</creatorcontrib><title>Role of Endothelin-1 in Blood Pressure Regulation in a Rat Model of Visceral Obesity and Hypertension</title><title>Hypertension (Dallas, Tex. 1979)</title><addtitle>Hypertension</addtitle><description>ABSTRACT—Endothelial dysfunction has been suggested to play an important role in the development of obesity-induced hypertension. Because endothelin release increases in response to endothelial damage, we examined whether endothelin-1 contributes to increased arterial pressure in a model of visceral obesity produced by feeding Sprague-Dawley rats a high-fat (HF) diet (40% fat w/w, n=6) for 12 months. Arterial and venous catheters were implanted for measurement of mean arterial pressure (MAP) and heart rate (HR) 24 hours per day and intravenous infusions. After a 5-day control period, rats were infused with the selective endothelin-1 type A receptor (ET-A) blocker ABT-627 (2.5 mg/kg per day, IV) for 9 days, followed by a recovery period. Rats fed a standard chow (normal fat, or NF, groupn=6) for 12 months were also infused with ET-A blocker and were used as controls. Compared with NF rats, HF rats had higher MAP (113±4 versus 98±2 mm Hg), increased visceral fat (18.7±2.0 versus 10.8±1.4 g), and 3.2-fold increase in plasma leptin despite similar total body weight gain. Long-term ET-A blockade markedly reduced MAP in HF (−14±3 mm Hg) and NF (−14±2 mm Hg), but it had no effect on HR, GFR, or PRA. These results indicate that a long-term HF diet may cause visceral obesity and increased MAP, even in the absence of major changes in total body weight. Endothelin-1 appears to play an important role in the maintenance of arterial pressure in rats fed HF and NF diets, but it does not appear to contribute to increased MAP in this model of diet-induced hypertension.</description><subject>Adipose Tissue - pathology</subject><subject>Animals</subject><subject>Arterial hypertension. Arterial hypotension</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Blood Pressure - drug effects</subject><subject>Body Weight</subject><subject>Cardiology. Vascular system</subject><subject>Clinical manifestations. Epidemiology. Investigative techniques. Etiology</subject><subject>Eating</subject><subject>Endothelin A Receptor Antagonists</subject><subject>Endothelin-1 - physiology</subject><subject>Experimental diseases</subject><subject>Fats - administration &amp; dosage</subject><subject>Heart Rate - drug effects</subject><subject>Hormones - blood</subject><subject>Hypertension - etiology</subject><subject>Hypertension - physiopathology</subject><subject>Kidney - drug effects</subject><subject>Kidney - physiopathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Obesity - complications</subject><subject>Obesity - etiology</subject><subject>Obesity - pathology</subject><subject>Pyrrolidines - pharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Viscera</subject><issn>0194-911X</issn><issn>1524-4563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkV9v0zAUxS3ExErhKyBrEntLZjv-k_AG00aRhjZVgODJcuwbmuHGxU409dvjrJUqcV-uLP-O7_E9CF1QUlIq6RWh5erXQ0ly0VxVUza8UnWp-Au0oILxggtZvUQLQhteNJT-PEevU3rMOOdcvULnlCuiqOQLBOvgAYcO3wwujBvw_VBQ3A_4kw_B4YcIKU0R8Bp-T96MfRjmS4PXZsRfgwM_a3_0yUI0Ht-3kPpxj83g8Gq_gzjCkLLmDTrrjE_w9tiX6PvtzbfrVXF3__nL9ce7wgpKZOFswy2zraNGikpIKfIXnZLSMVc1rRONsgpcVdU1qDafGq4MkUxZUgsnu2qJLg_v7mL4O0Ea9Xa25r0ZIExJ14SymnOZwYv_wMcwxSF704wIpmqW97pEHw6QjSGlCJ3exX5r4l5TouckNKE6J6FPSejnJLTiWfzuOGFqt-BO0uPqM_D-CJhkje-iGWyfTpwQtSJydsEP3FPwI8T0x09PEPUGjB83z6M5k3XBcieMUFLMZmT1D06Hn08</recordid><startdate>200402</startdate><enddate>200402</enddate><creator>da Silva, Alexandre A</creator><creator>Kuo, Jay J</creator><creator>Tallam, Lakshmi S</creator><creator>Hall, John E</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>200402</creationdate><title>Role of Endothelin-1 in Blood Pressure Regulation in a Rat Model of Visceral Obesity and Hypertension</title><author>da Silva, Alexandre A ; Kuo, Jay J ; Tallam, Lakshmi S ; Hall, John E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5106-dc94c2cbd1a6535665000d766d2d39bd597c7ed3388e7b597947a0627c085d6f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adipose Tissue - pathology</topic><topic>Animals</topic><topic>Arterial hypertension. Arterial hypotension</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Blood Pressure - drug effects</topic><topic>Body Weight</topic><topic>Cardiology. Vascular system</topic><topic>Clinical manifestations. Epidemiology. Investigative techniques. Etiology</topic><topic>Eating</topic><topic>Endothelin A Receptor Antagonists</topic><topic>Endothelin-1 - physiology</topic><topic>Experimental diseases</topic><topic>Fats - administration &amp; dosage</topic><topic>Heart Rate - drug effects</topic><topic>Hormones - blood</topic><topic>Hypertension - etiology</topic><topic>Hypertension - physiopathology</topic><topic>Kidney - drug effects</topic><topic>Kidney - physiopathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Obesity - complications</topic><topic>Obesity - etiology</topic><topic>Obesity - pathology</topic><topic>Pyrrolidines - pharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Viscera</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>da Silva, Alexandre A</creatorcontrib><creatorcontrib>Kuo, Jay J</creatorcontrib><creatorcontrib>Tallam, Lakshmi S</creatorcontrib><creatorcontrib>Hall, John E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>da Silva, Alexandre A</au><au>Kuo, Jay J</au><au>Tallam, Lakshmi S</au><au>Hall, John E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of Endothelin-1 in Blood Pressure Regulation in a Rat Model of Visceral Obesity and Hypertension</atitle><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle><addtitle>Hypertension</addtitle><date>2004-02</date><risdate>2004</risdate><volume>43</volume><issue>2, Part 2</issue><spage>383</spage><epage>387</epage><pages>383-387</pages><issn>0194-911X</issn><eissn>1524-4563</eissn><coden>HPRTDN</coden><abstract>ABSTRACT—Endothelial dysfunction has been suggested to play an important role in the development of obesity-induced hypertension. Because endothelin release increases in response to endothelial damage, we examined whether endothelin-1 contributes to increased arterial pressure in a model of visceral obesity produced by feeding Sprague-Dawley rats a high-fat (HF) diet (40% fat w/w, n=6) for 12 months. Arterial and venous catheters were implanted for measurement of mean arterial pressure (MAP) and heart rate (HR) 24 hours per day and intravenous infusions. After a 5-day control period, rats were infused with the selective endothelin-1 type A receptor (ET-A) blocker ABT-627 (2.5 mg/kg per day, IV) for 9 days, followed by a recovery period. Rats fed a standard chow (normal fat, or NF, groupn=6) for 12 months were also infused with ET-A blocker and were used as controls. Compared with NF rats, HF rats had higher MAP (113±4 versus 98±2 mm Hg), increased visceral fat (18.7±2.0 versus 10.8±1.4 g), and 3.2-fold increase in plasma leptin despite similar total body weight gain. Long-term ET-A blockade markedly reduced MAP in HF (−14±3 mm Hg) and NF (−14±2 mm Hg), but it had no effect on HR, GFR, or PRA. These results indicate that a long-term HF diet may cause visceral obesity and increased MAP, even in the absence of major changes in total body weight. Endothelin-1 appears to play an important role in the maintenance of arterial pressure in rats fed HF and NF diets, but it does not appear to contribute to increased MAP in this model of diet-induced hypertension.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>14707164</pmid><doi>10.1161/01.HYP.0000111139.94378.74</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0194-911X
ispartof Hypertension (Dallas, Tex. 1979), 2004-02, Vol.43 (2, Part 2), p.383-387
issn 0194-911X
1524-4563
language eng
recordid cdi_proquest_miscellaneous_80128446
source MEDLINE; American Heart Association Journals; EZB-FREE-00999 freely available EZB journals; Journals@Ovid Complete
subjects Adipose Tissue - pathology
Animals
Arterial hypertension. Arterial hypotension
Biological and medical sciences
Blood and lymphatic vessels
Blood Pressure - drug effects
Body Weight
Cardiology. Vascular system
Clinical manifestations. Epidemiology. Investigative techniques. Etiology
Eating
Endothelin A Receptor Antagonists
Endothelin-1 - physiology
Experimental diseases
Fats - administration & dosage
Heart Rate - drug effects
Hormones - blood
Hypertension - etiology
Hypertension - physiopathology
Kidney - drug effects
Kidney - physiopathology
Male
Medical sciences
Obesity - complications
Obesity - etiology
Obesity - pathology
Pyrrolidines - pharmacology
Rats
Rats, Sprague-Dawley
Viscera
title Role of Endothelin-1 in Blood Pressure Regulation in a Rat Model of Visceral Obesity and Hypertension
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T17%3A50%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20Endothelin-1%20in%20Blood%20Pressure%20Regulation%20in%20a%20Rat%20Model%20of%20Visceral%20Obesity%20and%20Hypertension&rft.jtitle=Hypertension%20(Dallas,%20Tex.%201979)&rft.au=da%20Silva,%20Alexandre%20A&rft.date=2004-02&rft.volume=43&rft.issue=2,%20Part%202&rft.spage=383&rft.epage=387&rft.pages=383-387&rft.issn=0194-911X&rft.eissn=1524-4563&rft.coden=HPRTDN&rft_id=info:doi/10.1161/01.HYP.0000111139.94378.74&rft_dat=%3Cproquest_cross%3E80128446%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=205278211&rft_id=info:pmid/14707164&rfr_iscdi=true